Inventor · disambiguated record
Benjamin Bonavida
Also filed as: BONAVIDA BENJAMIN
1 granted patent·9 pending applications·11 citations·filing 2001–2012
34Inventor score
Top patents by PatentIndex Score
10 records- 0170US7604809B2Reinforcing systemic immune responses with lactobacillus caseiGERVAIS DANONE SA·Filed 2001·Granted Oct 20, 2009·11 cites·12 claims
- 0248US2012282168A1Methods of sensitizing cancer to therapy-induced cytotoxicityBONAVIDA BENJAMIN·Filed 2012·Application pending·0 cites
- 0347US2009148445A1Methods of sensitizing cancer to therapy-induced cytotoxicityUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
- 0445US2009285836A1Use of salinosporamide a to inhibit metastasisNEREUS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0544US2009203050A1Molecular signaling pathways triggered by rituximab: prognostic, diagnostic, and therapeutic usesUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 0640US2007172847A1Molecular signaling pathways triggered by rituximab: prognostic, diagnostic, and therapeutic usesUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
- 0737US2008253966A1Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human CancerUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 0836US2008311039A1Therapeutic and Prognostic Factor Yy1 in Human CancerUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 0934US2001038832A1Nitric oxide and analogues thereof effectuate sensitization of neoplasm and immunologically undesired tissues to cytotoxicityFiled 2001·Application pending·0 cites
- 1023US2001053772A1Aza analogues of alkyl lysophospholipids exert immunomodulatory effectsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →